Canopy Growth CGC
NASDAQ CGC
$1.03 0.00 (-0.48%)
At close: Aug 20, 2026 · 12:52 PM UTC

Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2026)

Canopy Growth (CGC) posted Other Non-Current Liabilities of $27.3 million for Q1 2026, up 244.31% sequentially from $7.9 million in Q4 2025, and up 7.81% YoY from $25.3 million in Q1 2025.

Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Canopy Growth has reported Other Non-Current Liabilities for 10 years, with the latest figure at $27.3 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 7.81% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.3 million (up 7.81% YoY) and the FY2026 annual result came in at $27.3 million, up 7.81% from the prior year.
  • Other Non-Current Liabilities advanced to $27.3 million in Q1 2026 per CGC's latest filing, from $7.9 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $73.4 million in Q2 2023 and troughed at $529821.7 in Q3 2022.
  • A 5-year average of $25.4 million and a median of $22.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 99.37% in 2022, then jumped 2808.56% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $29.4 million in 2022, then tumbled by 76.19% to $7.0 million in 2023, then soared by 242.51% to $24.0 million in 2024, then plunged by 66.97% to $7.9 million in 2025, then soared by 244.31% to $27.3 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $27.3 million, $7.9 million, and $11.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Canopy Growth 437.04 Mn 190.03 Mn 16.08 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.14 Mn
Mar 31, 2026 27.25 Mn
Dec 31, 2025 7.92 Mn
Sep 30, 2025 11.13 Mn
Jun 30, 2025 8.65 Mn
Mar 31, 2025 25.28 Mn
Dec 31, 2024 23.97 Mn
Sep 30, 2024 33.25 Mn
Jun 30, 2024 48.11 Mn
Mar 31, 2024 53.29 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 15.41 Mn
Jun 30, 2023 73.36 Mn
Dec 31, 2022 29.39 Mn
Sep 30, 2022 529,821.66
Jun 30, 2022 20.86 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 155.19 Mn
Sep 30, 2021 84.06 Mn
Jun 30, 2021 88.71 Mn